An abstract approach to the regulation of human genetics: Law, morality and social policy

The Regulatory Challenge of Biotechnology: Human Genetics, Food and Patents

Volumn , Issue , 2007, Pages 63-92

  Burley, Justine ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881736665     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (65)

1. Anderson, E.S. (1999), 'What is the Point of Equality?', Ethics, 109, 287-337.
2. Association of British Insurers (1997), Genetic Testing: ABI Code of Practice, London: Association of British Insurers.
3. Australia (2002), Research Involving Human Embryos Act 2002.
4. Bioethics Advisory Committee (2005), Ethical, Legal and Social Issues in Genetic Testing and Genetics Research: A Consultation Paper, Singapore.
5. Burley, Justine C. (2005), 'Translational Medicine in Stem Cell Research', in Ariff
6. Bongso and Eng Hin Lee (eds), Stem Cells: From Bench to Bedside, Singapore: World Scientific Publishing.
7. Canada (2004), Bill C-6: An Act Respecting Assisted Human Reproduction and Related Research, 27 March.
8. Cello, J., A.V. Paul and E. Wimmer (2002), 'Chemical Synthesis of Poliovirus cDNA: Generation of Infectious Virus in the Absence of Natural Template', Science, 297, 1016-18.
9. Clayton, Matthew and Andrew Williams (eds) (2000), The Ideal of Equality, London: Macmillan Press.
10. Cohen, Gerald A. (2004), 'Expensive Taste Rides Again', in Justine C. Burley (ed.), Ronald Dworkin and His Critics, Oxford: Blackwell, pp. 3-29.
11. Convention on Human Rights and Biomedicine (1997), 'Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine 1997', Oviedo, 4 April.
12. Daniels, Norman, Donald Light and Ronald Caplan (1996), Benchmarks of Fairness for Health Care Reform, New York: Oxford University Press.
13. de Beaufort, Inez (2002), 'Justice, Genetics and Lifestyles', in Justine C. Burley and John Harris (eds), A Companion to Genethics, Oxford: Blackwell, pp. 325-33.
14. Denmark (1997), Act No. 460 on Medically Assisted Procreation in Connection with Medical Treatment, Diagnosis and Research, 10 June (amended 1 September 2003) and Act No. 503 on a Scientific, Ethical Committee System and the Handling of Biomedical Research Projects.
15. Dworkin, Ronald (1993), Life's Dominion: An Argument about Abortion, Euthanasia, and Individual Freedom, New York: Alfred Knopf.
16. Dworkin, Ronald (2000), Sovereign Virtue: The Theory and Practice of Equality, Cambridge, MA: Harvard University Press.
17. ESHG, PPPC (January 2000), European Society of Human Genetics, Public and Professional Policy Committee, 'Genetic Information and Testing in Insurance and Employment: Technical, Social and Ethical Issues, EUROGAPP Project 1999-2000', http://www.eshg.org/.
18. Estonia (1997), Embryo Protection and Artificial Fertilisation Act.
19. Ewald, Francois (1999),'Genetics, Insurance and Risk', in Tony McGleenan, Urban Wiesing and Francois Ewald (eds), Genetics and Insurance, Oxford: BIOS Scientific Publishers Ltd.
20. Finland (1999), Law 488/1999.
21. Greece (2002), Law No. 3089 on Medically Assisted Reproduction.
22. Gurdon, J.B. (1962), 'The Developmental Capacity of Nuclei Taken From Intestinal Epithelial Cells of Feeding Tadpoles', Journal of Embryology and Experimental Morphology, 10, 662-740.
23. HM Government and ABI (2005), Concordat and Moratorium on Genetics and Insurance 2005, London: Department of Health.
24. Hong Kong (2000), Human Reproductive Technology Ordinance. Human Fertilisation and Embryology Act (1990), www.hmso.gov.uk/acts/acts1990/Ukpga_19900037_en_2.htm.
25. Human Genetics Advisory Commission (1997), The Implications of Genetic Testing for Insurance, London: Department of Trade and Industry.
26. Hwang, W.S., Y.J. Ryu, J.H. Park, E.S. Park, E.G. Lee, J.M. Koo, H.Y. Jeon, B.C. Lee and S.K. Kang (2004), 'Reports - Developmental Biology'. Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst', Science, 303(5664), 1669-73.
27. Iceland (1996), Act on Artificial Fertilization, 55/1996.
28. Indian Council of Medical Research (ICMR) (2004), Draft Guidelines for Stem Cell Research/Regulation in India.
29. Irish Insurance Federation (2001), Code of Practice on Genetic Testing, Dublin: Irish Insurance Federation, www.iif.ie/media.htm.
30. Knoppers, Bartha M. (1999), 'Who Should Have Access to Genetic Information?', in Justine C. Burley (ed.), The Genetic Revolution and Human Rights, Oxford: Oxford University Press.
31. Knoppers, Bartha M., Béatrice Godard and Yann Joly (2004), 'Life Insurance and Genetics: A Comparative, International Overview', in Mark A. Rothstein (ed.), Life Insurance: Medical Underwriting and Social Policy, Boston: MIT Press.
32. Laurie, Graeme, T. (2002), Genetic Privacy: A Challenge to Medico-legal Norms, Cambridge: Cambridge University Press.
33. Lawton, A. (1997), 'Regulating Genetic Destiny: A Comparative Study of Legal Constraints in Europe and the United States', Emory International Law Review, 11(2), 365-418.
34. Lemmens, T. (2003), 'Genetics and Insurance Discrimination: Comparative Legislative, Regulatory and Policy Developments and Canadian Options', Health Law Journal, 41-86.
35. Macleod, Colin M. (1998), Liberalism, Justice and Markets, Oxford: Clarendon Press.
36. McGleenan, T. and U. Wiesing (2000), 'Insurance and Genetics: European Policy Approaches', European Journal of Health Law, 7, 367-85.
37. McGleenan, Tony, Urban Wiesing and Francois Ewald (eds) (1999), Genetics and Insurance, Oxford: BIOS Scientific Publishers Ltd.
38. Ministry of Health (2003), 'Ethical Principles on Assisted Reproductive Technologies for Human Beings and Human Sperm Bank', October.
39. Netherlands (2000), Bill Containing Rules Relating to the Use of Gametes and Embryos (Embryos Bill), Parliamentary Documents II, 2000/01, 27 423, Nos. 1-2.
40. New Zealand (2004), Human Assisted Reproductive Technology Bill (HART), October.
41. NIH Human Embryonic Stem Cell Registry, http://stemcells.nih.gov/research/ registry/index.asp.
42. Otlowski, Margaret (2001), 'Implications of Genetic Testing for Australian Insurance Law and Practice' (Occasional Paper No.1), Tasmania: Law and Genetics Centre.
43. Rawls, John B. (1971), A Theory of Justice, Cambridge, MA: Belknap Press.
44. Republic of South Africa (2003), National Health Bill.
45. Roemer, John E. (1994), Egalitarian Perspectives, Cambridge, UK: Cambridge University Press.
46. Rothstein, Mark A. (ed.) (2004), Life Insurance: Medical Underwriting and Social Policy, Boston: MIT Press.
47. Savulescu, J. and J. Harris (2004), 'The Creation Lottery: Final Lessons from Natural Reproduction: Why Those Who Accept Natural Reproduction Should Accept Cloning and Other Frankenstein Reproductive Technologies', Cambridge Quarterly of Healthcare Ethics, 13(1), 90-95.
48. Service Public Federal Santé Publique, Securité de la Chaine Alimentaire et Environnement (2003), 'Loi Relative à la Recherche sur les Embryons In Vitro', 11 May.
49. Silver, Lee (1997), Remaking Eden: How Genetic Engineering and Cloning Will Transform the American Family, New York: Avon Books.
50. Singapore, Parliament of Singapore (2004), Human Cloning and Other Prohibited Practices Bill, bill no. 34/2004, first read 20 July 2004.
51. Sorrell, Tom (2002), 'The Insurance Market and Discriminatory Practices', in Justine C. Burley and John Harris (eds), A Companion to Genethics, Oxford: Blackwell, pp. 398-407.
52. South Korea (2004), Life Ethics Law, 29 January.
53. Spain (2003), Boletín Oficial del Estado, Ley 45/2003, de 21 de noviembre, por la que se modifica la Ley 35/1988, de 22 de noviembre.
54. Steiner, Hillel (1994), An Essay on Rights, Oxford: Blackwell.
55. Sweden (2004), Government Bill 2003/04: '148' and Committee on Health and Welfare Report 2004/05: 'SoU7', November.
56. Symposium on Ronald Dworkin's Sovereign Virtue (2002), Ethics, 113(1).
57. Taiwan (2002), Taiwan Department of Health, Ethical Regulations for Embryonic Stem Cell Research.
58. Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A. Waknitz, J.J. Swiergiel, V.S. Marshall and J.M. Jones (1998), 'Embryonic Stem Cell Lines Derived From Human Blastocysts', Science, 282(5391), 1145-7.
59. UK Genetics and Insurance Committee (2000), Decision of the Genetics and Insurance Committee Concerning the Application for Approval to Use Genetic Test Results for Life Insurance Risk Assessment in Huntington's Disease, London: GAIC.
60. UK Human Genetics Commission (2005), 'Profiling the Newborn: a Prospective Gene Technology?', www.hgc.gov.uk, March.
61. UNESCO (1997), 'Universal Declaration on the Human Genome and Human Rights', adopted by the General Conference of UNESCO at its 29th session on 11 November 1997.
62. United Nations Fifty-ninth General Assembly (2005), Plenary, 82nd Meeting (AM), Press Release GA/10333, 3 March.
63. van Parijs, Philippe (2004), 'Equality of Resources versus Undominated Diversity', in Justine C. Burley (ed.), Ronald Dworkin and His Critics, Oxford: Blackwell, pp. 45-69.
64. Wilmut, I., A.E. Schnieke, J. McWhir, A.J. Kind and K.H.S. Campbell (1997), 'Viable Offspring Derived from Fetal and Adult Mammalian Cells', Nature, 385, 810-13.
65. World Stem Cell Map (2005), compiled by William Hoffman, http://mbbnet.umn.edu/scmap.html, 17 October.